Effect of nephrotoxicants and hepatotoxicants on gene expression profile in human peripheral blood mononuclear cells

Biochemical and Biophysical Research Communications

Volumn 401, Issue 2, 2010, Pages 245-250

  Dadarkar, Shruta S ^a   Fonseca, Lyle C ^a   Thakkar, Arvind D ^a   Mishra, Prabha B ^a   Rangasamy, Ashok K ^b   Padigaru, Muralidhara ^a  

^a Piramal Enterprises Limited   (India)

^b VIT UNIVERSITY   (India)

Author keywords

Hepatotoxicity; Microarray; Nephrotoxicity; Toxicogenomics

Indexed keywords

AMPHOTERICIN B; CISPLATIN; CYCLOPHOSPHAMIDE; FLUCONAZOLE; GENTAMICIN; ISONIAZID; PARACETAMOL; ROSIGLITAZONE;

ARTICLE; CLINICAL CHEMISTRY; DRUG EXPOSURE; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER TOXICITY; MICROARRAY ANALYSIS; NEPHROTOXICITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELLS, CULTURED; DRUG TOXICITY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; KIDNEY; LEUKOCYTES, MONONUCLEAR; LIVER; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 77957760702     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.09.039     Document Type: Article

References (28)

1. Zhou T., Chou J., Watkins P.B., Kaufmann W.K. Toxicogenomics: transcription profiling for toxicology assessment. Exs 2009, 99:325-366.
2. Wang E.J., Snyder R.D., Fielden M.R., Smith R.J., Gu Y.Z. Validation of putative genomic biomarkers of nephrotoxicity in rats. Toxicology 2008, 246:91-100.
3. Rockett J.C., Burczynski M.E., Fornace A.J., Herrmann P.C., Krawetz S.A., Dix D.J. Surrogate tissue analysis: monitoring toxicant exposure and health status of inaccessible tissues through the analysis of accessible tissues and cells. Toxicol. Appl. Pharmacol. 2004, 194:189-199.
4. Vass L., Kelemen J.Z., Feher L.Z., Lorincz Z., Kulin S., Cseh S., Dorman G., Puskas L.G. Toxicogenomics screening of small molecules using high-density, nanocapillary real-time PCR. Int. J. Mol. Med. 2009, 23:65-74.
5. Kiyosawa N., Ando Y., Watanabe K., Niino N., Manabe S., Yamoto T. Scoring multiple toxicological endpoints using a toxicogenomic database. Toxicol. Lett. 2009, 188:91-97.
6. Umbright C., Sellamuthu R., Li S., Kashon M., Luster M., Joseph P. Blood gene expression markers to detect and distinguish target organ toxicity. Mol. Cell. Biochem. 2010, 335:223-234.
7. Mohr S., Liew C.C. The peripheral-blood transcriptome: new insights into disease and risk assessment. Trends Mol. Med. 2007, 13:422-432.
8. Nakamura S., Kobayashi M., Sugino T., Kajimoto O., Matoba R., Matsubara K. Effect of exercise on gene expression profile in unfractionated peripheral blood leukocytes. Biochem. Biophys. Res. Commun. 2010, 391:846-851.
9. Ryan T.P., Stevens J.L., Thomas C.E. Strategic applications of toxicogenomics in early drug discovery. Curr. Opin. Pharmacol. 2008, 8:654-660.
10. Lavallie E.R., Dorner A.J., Burczynski M.E. Use of ex vivo systems for biomarker discovery. Curr. Opin. Pharmacol. 2008, 8:647-653.
11. Radich J.P., Mao M., Stepaniants S., Biery M., Castle J., Ward T., Schimmack G., Kobayashi S., Carleton M., Lampe J., Linsley P.S. Individual-specific variation of gene expression in peripheral blood leukocytes. Genomics 2004, 83:980-988.
12. Whitney A.R., Diehn M., Popper S.J., Alizadeh A.A., Boldrick J.C., Relman D.A., Brown P.O. Individuality and variation in gene expression patterns in human blood. Proc. Natl. Acad. Sci. USA 2003, 100:1896-1901.
13. Eady J.J., Wortley G.M., Wormstone Y.M., Hughes J.C., Astley S.B., Foxall R.J., Doleman J.F., Elliott R.M. Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. Physiol. Genomics 2005, 22:402-411.
14. Watkins N.A., Gusnanto A., de Bono B., De S., Miranda-Saavedra D., Hardie D.L., Angenent W.G., Attwood A.P., Ellis P.D., Erber W., Foad N.S., Garner S.F., Isacke C.M., Jolley J., Koch K., Macaulay I.C., Morley S.L., Rendon A., Rice K.M., Taylor N., Thijssen-Timmer D.C., Tijssen M.R., van der Schoot C.E., Wernisch L., Winzer T., Dudbridge F., Buckley C.D., Langford C.F., Teichmann S., Gottgens B., Ouwehand W.H. A HaemAtlas: characterizing gene expression in differentiated human blood cells. Blood 2009, 113:e1-e9.
15. Bhonde M.R., Gupte R.D., Dadarkar S.D., Jadhav M.G., Tannu A.A., Bhatt P., Bhatia D.R., Desai N.K., Deore V., Yewalkar N., Vishwakarma R.A., Sharma S., Kumar S., Dagia N.M. A novel mTOR inhibitor is efficacious in a murine model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 295:G1237-G1245.
16. Dagia N.M., Gadhoum S.Z., Knoblauch C.A., Spencer J.A., Zamiri P., Lin C.P., Sackstein R. G-CSF induces E-selectin ligand expression on human myeloid cells. Nat. Med. 2006, 12:1185-1190.
17. Dagia N.M., Kamath D.V., Bhatt P., Gupte R.D., Dadarkar S.S., Fonseca L., Agarwal G., Chetrapal-Kunwar A., Balachandran S., Srinivasan S., Bose J., Pari K., Rao C.B., Parkale S.S., Gadekar P.K., Rodge A.H., Mandrekar N., Vishwakarma R.A., Sharma S. A fluorinated analog of ISO-1 blocks the recognition and biological function of MIF and is orally efficacious in a murine model of colitis. Eur. J. Pharmacol. 2009, 607:201-212.
18. Thakkar A.D., Raj H., Chakrabarti D., Ravishankar P., Saravanan N., Muthuvelan B., Balakrishnan A., Padigaru M. Identification of gene expression signature in estrogen receptor positive breast carcinoma. Biomarkers Cancer 2010, 2:1-15.
19. Smalley J.L., Gant T.W., Zhang S.D. Application of connectivity mapping in predictive toxicology based on gene-expression similarity. Toxicology 2010, 268:143-146.
20. Mendrick D.L. Genomic and genetic biomarkers of toxicity. Toxicology 2008, 245:175-181.
21. Burczynski M.E., Dorner A.J. Transcriptional profiling of peripheral blood cells in clinical pharmacogenomic studies. Pharmacogenomics 2006, 7:187-202.
22. Baranzini S.E., Mousavi P., Rio J., Caillier S.J., Stillman A., Villoslada P., Wyatt M.M., Comabella M., Greller L.D., Somogyi R., Montalban X., Oksenberg J.R. Transcription-based prediction of response to IFNbeta using supervised computational methods. PLoS Biol. 2005, 3:e2.
23. Burczynski M.E., McMillian M., Ciervo J., Li L., Parker J.B., Dunn R.T., Hicken S., Farr S., Johnson M.D. Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. Toxicol. Sci. 2000, 58:399-415.
24. Feezor R.J., Baker H.V., Mindrinos M., Hayden D., Tannahill C.L., Brownstein B.H., Fay A., MacMillan S., Laramie J., Xiao W., Moldawer L.L., Cobb J.P., Laudanski K., Miller-Graziano C.L., Maier R.V., Schoenfeld D., Davis R.W., Tompkins R.G. Whole blood and leukocyte RNA isolation for gene expression analyses. Physiol. Genomics 2004, 19:247-254.
25. Hirakawa B., Jessen B.A., Illanes O., Peyster A.D., McDermott T., Stevens G.J. Toxicogenomic analysis of cardiototxicity in Rats. Genomics Insights 2008, 1:3-13.
26. R.H. Segman, T. Goltser-Dubner, I. Weiner, L. Canetti, E. Galili-Weisstub, A. Milwidsky, V. Pablov, N. Friedman, D. Hochner-Celnikier, Blood mononuclear cell gene expression signature of postpartum depression, Mol. Psychiatry 15 (2010) 93-100, 102.
27. Ingelman-Sundberg M. Genetic variability in susceptibility and response to toxicants. Toxicol. Lett. 2001, 120:259-268.
28. Goodsaid F.M. Genomic biomarkers of toxicity. Curr. Opin. Drug Discov. Dev. 2003, 6:41-49.